The International Journal of Medical Science and Health Research
Vol. 49 No. 2 (2026): The International Journal of Medical Science and Health Research

CYTOKINE BIOMARKERS FOR THE PREDICTION OF CYTOKINE RELEASE SYNDROME IN CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY: A COMPREHENSIVE SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS AND PRIMARY STUDIES

Muhammad Thoriq Alhabib (General Practitioner, Karya Medika 1 General Hospital, Indonesia / Graduate of Faculty of Medicine, University of Andalas, Indonesia)
Namira Assyfa Nurazizah (General Practitioner, Majalengka Regional General Hospital, Indonesia / Graduate of Faculty of Medicine, Padjadjaran University, Indonesia)
Fikri Arif Muhammad (General Practitioner, Dustira Level II Military Hospital, Indonesia / Graduate of Faculty of Medicine, Padjadjaran University, Indonesia)
Chaerunnisa Auliya Putu Sugiyarti (General Practitioner, dr. Soeratno Gemolong Regional General Hospital, Indonesia / Graduate of Faculty of Medicine, Muhammadiyah University of Yogyakarta, Indonesia)
Greatavia Meanda Leslie (General Practitioner, Bethesda General Hospital, Indonesia / Graduate of Faculty of Medicine, Duta Wacana Christian University, Indonesia)
Srigita Varsha (General Practitioner, dr. T. C. Hillers Regional General Hospital, Indonesia / Graduate of Faculty of Medicine, Padjadjaran University, Indonesia)
Dwi Putri Wijayanti (General Practitioner, Darul Istiqomah Kendal General Hospital, Indonesia / Graduate of Faculty of Medicine, Sultan Agung Islamic University, Indonesia)
Fitri Nurina Septiana (General Practitioner, Annisa Medika Husada Mother and Child Hospital, Indonesia / Graduate of Faculty of Medicine, Airlangga University, Indonesia)
Bernita Nur Cahyani (General Practitioner, Surakarta Central General Hospital, Indonesia / Graduate of Faculty of Medicine, Gadjah Mada University, Indonesia)
Shelda Syifa’ Azzahra (General Practitioner, Udayana Level II Military Hospital, Indonesia / Graduate of Faculty of Medicine, Syiah Kuala University, Indonesia)
Muhamad Luthfi Asyhar (General Practitioner, Waras Wiris Regional General Hospital, Indonesia / Graduate of Faculty of Medicine, Airlangga University, Indonesia)
Charles Sanjaya (Internal Medicine Specialist, Kebonjati General Hospital, Indonesia)



Article Info

Publish Date
30 Oct 2026

Abstract

Background. Cytokine release syndrome (CRS) remains the defining acute toxicity of chimeric antigen receptor (CAR) T-cell therapy, and the capacity to identify, before clinical deterioration, the minority of recipients who will progress to high-grade disease would allow pre-emptive rather than reactive management. Individual cohorts have nominated a long list of candidate cytokine biomarkers, but their effect sizes, measurement windows and discriminative performance have never been quantitatively consolidated across the full breadth of CAR-T indications. Objective. To quantify the association between circulating cytokine biomarkers and severe CRS after CAR-T cell therapy, to compare cytokines with routinely available acute-phase and endothelial indices, and to estimate the discriminative accuracy of composite multi-analyte models. Methods. The study strictly adhered to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines. Randomised controlled trials, comparative studies, cohort studies and case series of at least ten patients that reported a quantified cytokine biomarker and graded CRS were eligible; systematic reviews and meta-analyses were excluded from pooling and reserved for contextual discussion. Risk of bias was appraised with ROBINS-I and Cochrane RoB 2. DerSimonian–Laird random-effects models pooled odds ratios per ten-fold increment of each analyte, with prediction intervals, Egger and Begg tests, trim-and-fill, leave-one-out influence analysis, meta-regression and GRADE certainty rating. Diagnostic accuracy of composite models was synthesised bivariately with a summary receiver-operating characteristic curve. Results. Thirty-two primary studies comprising 4,381 participants were included, of which 27 contributed to quantitative synthesis. Interferon-gamma showed the strongest pooled association with severe CRS (odds ratio 2.65 (95% CI 2.13–3.30); I² 34%), followed by interleukin-6 (2.49 (95% CI 2.06–3.01); I² 35%), the monocyte–macrophage chemokine axis of interleukin-8 and MCP-1 (2.24 (95% CI 1.77–2.83)), interleukin-10 (2.15 (95% CI 1.78–2.60)), interleukin-2 and its soluble receptor (1.84 (95% CI 1.45–2.35)) and interleukin-15 (1.70 (95% CI 1.36–2.11)). Tumour necrosis factor-alpha was not significantly associated with severe CRS (1.18 (95% CI 0.96–1.46)). Acute-phase reactants performed materially less well than effector cytokines (1.50 (95% CI 1.30–1.74)), whereas the endothelial activation and stress index separated severe from non-severe disease with a standardised mean difference of 0.49 (95% CI 0.34–0.63). Pre-infusion composite models carried a pooled odds ratio of 2.01 (95% CI 1.70–2.38), significantly weaker than post-infusion sampling (1.60 versus 2.19; P for interaction = 0.002). Composite multi-analyte models achieved a pooled sensitivity of 77.2% (95% CI 70.5–82.7), specificity of 84.4% (79.0–88.6) and a diagnostic odds ratio of 21.0, with a mean reported area under the curve of 0.85. Certainty of evidence was low for most individual analytes and moderate for EASIX. Conclusions. Effector cytokines generated by the CAR T cell itself and by the myeloid compartment it recruits are reproducibly associated with severe CRS, and composite models combining two or three analytes with a routine haematological variable approach the discriminative performance required for clinical deployment. The evidence base is nonetheless constrained by platform heterogeneity, in-sample threshold derivation and the near-absence of randomised evidence for biomarker-triggered intervention. A biomarker-stratified randomised trial of pre-emptive cytokine blockade is now the logical and overdue next step.

Copyrights © 2026






Journal Info

Abbrev

ijmhsr

Publisher

Subject

Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary

Description

The International Journal of Medical Science and Health Research, published by International Medical Journal Corp. Ltd. is dedicated to providing physicians with the best research and important information in the world of medical research and science and to present the information in a format that ...